11th Sep 2023 A plain language summary of the INTRIGUE study comparing ripretinib with sunitinib in people with advanced gastrointestinal stromal tumour after treatment with imatinib
18th Oct 2021 Ripretinib for advanced gastrointestinal stromal tumor: Plain language summary of the INVICTUS study